Protocol-directed prostate cancer active surveillance offers acceptable oncologic safety. Protocol-directed active surveillance of localized prostate cancer reduces unnecessary treatment of men ...

Confirmatory or systematic prostate biopsies may be unnecessary for men considering active surveillance for prostate cancer who have negative findings on multiparametric MRI scans. Multiparametric MRI ...

Half of men with low-risk prostate cancer remained free from progression or treatment 10 years after diagnosis when followed in a protocol-directed active surveillance program. At 10 years, 43% of ...

Results from the Canary PASS study show good health outcomes among patients taking part in active surveillance over nearly 10 years of follow-up. Prostate cancer is frequently slow-growing, leading to ...

Please provide your email address to receive an email when new articles are posted on . Results refute criticisms about “losing a window of curability when delaying treatment.” Researchers estimated ...

Although about 1 in 8 men in the U.S. will be diagnosed with prostate cancer during their lifetime, only about 1 in 44 will die from it. Most men diagnosed with prostate cancer die from other causes, ...

If your cancer is not causing any symptoms, is growing slowly, or is small and only in your prostate, your physician may suggest active surveillance or watchful waiting instead of treatment. Active ...

About one in eight men in the U.S. are diagnosed with prostate cancer during their lifetime. However, up to 40 percent of ...

A cancer diagnosis is serious, but immediately starting treatment sometimes isn't the best course of action. ljubaphoto/E+ via Getty Images Although about 1 in 8 men in the U.S. will be diagnosed with ...

An error has occurred. Please try again. With a Lewiston Sun Journal subscription, you can gift 5 articles each month. It looks like you do not have any active ...

Former NIH director Francis Collins, MD, PhD, one of America's most prominent physicians and the leader of the ground-breaking Human Genome Project, has gone public with his "aggressive" prostate ...